NextFin

How Private Equity Ended Up in Limbo

Summarized by NextFin AI
  • Private equity holds a record 33,575 unsold companies, a backlog that has more than doubled in a decade and grown by over 1,100 in six months, as higher capital costs prevent exits at investor-acceptable prices.
  • 2025 deal value hit the second-best total in history, driven by megadeals like the $56.6 billion Electronic Arts take-private, yet exit volume fell 2% year over year to 1,570 and average holding periods stretched to about seven years.
  • Distributions to limited partners stayed below 15% of NAV for four consecutive years, an industry record, while fundraising dropped more than 30% from 2023 and new firm launches fell 6% to 134 in 2025.
  • The industry faces a structural break rather than a cyclical dip, with permanently expensive leverage, scale that outpaces exit capacity, and a broken LP compact that will reshape private equity into a smaller, slower-turning business.

NextFin News - Private equity is sitting on 33,575 unsold companies, a record pile of assets that has grown by more than 1,100 in just six months and more than doubled in a decade. The industry that built its reputation on buying, improving and selling companies within five to seven years now cannot sell them at prices its own investors will accept. After three years of near-frozen exits, a higher-cost capital regime has left private equity in limbo - trapped between paper valuations marked during the cheap-money boom and what buyers are willing to pay today.

The paradox is that dealmaking itself has revived. Global buyout deal and exit value surged in 2025 to the second-best totals in industry history, and the $56.6 billion take-private of Electronic Arts became the largest buyout ever recorded. Yet the recovery is narrow, powered by megadeals that did little to drain the backlog. Exit volume - the number of transactions - was 1,570 in 2025, down 2% year over year and barely above pre-pandemic levels, while the average holding period at exit has stretched to about seven years, up from five to six years between 2010 and 2021. Almost 40% of portfolio companies are now held for more than five years, up from 29% in 2019.

The consequence is a liquidity squeeze at the core of the private equity model. Distributions to limited partners as a percentage of net asset value have stayed below 15% for four consecutive years, an industry record. Fundraising has fallen more than 30% from 2023, and the number of new private equity firm launches dropped 6% to 134 in 2025. The industry is not in a cyclical dip; it is in a structural bind created when the era of near-zero rates ended, and the way out is measured in years, not quarters.

The Exit Machine That Stopped

Private equity's business model is simple in outline: borrow cheaply, buy a company, lift its earnings, then sell it - ideally within a fund's ten-year life. That cycle depends on willing buyers and a capital market that accepts the seller's price. Both conditions broke down after 2022, when central banks raised rates at the fastest pace in a generation and public-market multiples contracted.

The arithmetic is unforgiving. A company bought at a high multiple with cheap debt needs either earnings growth or a stable exit multiple to deliver the returns promised to pension funds and endowments. When exit multiples compress while borrowing costs rise, the gap between what a sponsor needs and what a buyer will pay becomes a chasm. Sponsors respond by waiting - extending holding periods in the hope that earnings catch up to the price. Bain's analysis of fifteen years of buyout vintages, from 2000 through 2015, shows that internal rates of return begin to stagnate around year seven and decline thereafter. Holding longer is not a neutral choice; it is a slow erosion of the very returns the industry sells.

The backlog is the physical evidence of that choice. As of June 30, 2026, private equity firms held 33,575 unsold companies, according to PitchBook data reported across industry coverage - up from 32,451 at the end of 2025 and from 15,923 a decade ago. Bain's 2026 outlook puts the unsold inventory at roughly 32,000 companies worth $3.8 trillion. The two counts differ in methodology, but they point to the same conclusion: the stock of assets awaiting exit has swollen to a size the industry has never had to work through.

This is not a uniform freeze. The strongest assets - those with defensible earnings, domestic revenue streams, or strategic relevance to corporate buyers - still clear the market. Bain noted greater buyer interest in companies with physical or labor-intensive operations and domestically oriented revenue in mid-2026. The assets stuck in limbo are the ones whose value story depended on multiple expansion and cheap leverage rather than operational improvement. The industry's problem is not that nothing sells; it is that what remains unsold is increasingly the hard case.

The median holding period tells the same story from the other direction. Median time to exit stretched from 4.3 years in 2017 to 5.4 years in 2024, and only saw its first decline in five years in 2025 - a tentative sign that the strongest assets are finally moving, while the long tail keeps waiting.

Why the Recovery Has Not Cleared the Backlog

The 2025 rebound in deal value created an illusion of momentum. Megadeals dominated the landscape, and those transactions were financed in ways that bypassed the buyout industry's own liquidity problem. Sovereign wealth funds and large corporations directly supplied much of the capital for the biggest deals, meaning buyout dry powder was only a fraction of the total. The six largest publicly listed US managers - Apollo, Ares, Blackstone, Carlyle, KKR and TPG - oversaw a combined $635 billion in traditional private equity assets and raised $65 billion in buyout capital in 2025, yet their combined dry powder still rose to more than $211 billion by the third quarter of 2025, up from $138 billion in the third quarter of 2020.

In other words, even a record year for deal value added to the stock of unspent capital rather than drawing it down. The industry's own success at gathering assets has become part of its trap.

The exit channels that normally drain the backlog have reopened only partially, and each route has a ceiling. The IPO window, the cleanest path for sponsors to monetize at full valuation, thawed with the Medline listing in December 2025 - the largest private-equity-backed IPO ever, raising more than $7 billion in gross proceeds. Shares priced at $29 and closed their debut more than 41% higher at $41, giving the company a market value of roughly $54 billion and signaling that public investors would pay for quality. Analysts at JPMorgan and Morgan Stanley estimated that private-equity-backed companies could account for up to one-third of all IPO activity in 2026, a measure of the pent-up supply waiting behind the door. But a reopened window is not the same as an open door: IPO volume remains a fraction of 2021 levels, and post-listing performance will determine whether the pipeline actually moves.

Sponsor-to-sponsor sales have filled more of the gap, but they move the problem rather than solve it. In Europe, sponsor-to-sponsor deals made up 76.1% of private equity exit value in the first quarter of 2026, up from 49.6% for the full year 2025, according to PitchBook. In the US they accounted for around half of exits in 2025, up from 42% in 2024. Selling one private equity-owned company to another does not return capital to the system; it transfers the asset, and the valuation gap, from one balance sheet to another. Strategic corporate buyers are the true drain on the backlog, and their appetite is selective - driven by specific assets rather than a broad willingness to pay sponsor prices.

The second-order effect is now visible in fundraising, where the limbo lands hardest. Limited partners commit capital on the promise of distributions, and when distributions stall, new commitments follow. Fundraising in 2025 marked a second consecutive year of decline, down more than 30% from 2023. Only 310 vehicles closed in the first half of 2026, the lowest half-year count in recent memory, even as top-tier managers with strong distribution records continued to raise record funds. The market is bifurcating: capital is concentrating with established firms that have returned cash, while weaker managers face a funding cliff. Industry observers expect further consolidation as some firms shrink, merge, or quietly stop raising new funds.

The Fee Model Meets the Liquidity Wall

Beneath the headline numbers lies a mismatch baked into the private equity compensation structure. General partners earn management fees on assets under management and carried interest on realized gains. When exits stall, fees keep accruing on paper valuations while carried interest goes unrealized - and limited partners cannot access their capital. The longer assets sit, the more the fee model rewards patience for the manager while punishing the investor waiting for distributions.

This misalignment has spawned a secondary market that is becoming a permanent feature rather than a release valve. Secondary sales of private equity stakes are likely to remain elevated as large allocators seek liquidity, flexibility, and a way to consolidate manager rosters. GP-led continuation vehicles, which let a manager roll assets into a new vehicle rather than sell them, now account for less than 10% of exit value - a partial fix that eases pressure but does not return capital to the broader pool of limited partners. Net asset value-backed loans offer another stopgap, letting funds borrow against marked portfolios. Each mechanism buys time; none clears the backlog.

The risk embedded in these structures is valuation. Loans and continuation vehicles are priced off the same marked values that sponsors would struggle to realize in an actual sale. If exits eventually happen at prices below those marks, the leverage layered on top of the marks amplifies the loss. That is the quiet danger of a limbo that has lasted long enough for financial engineering to grow around it.

Cyclical Pause or Structural Break?

The central question for investors in private equity is whether this is a cycle that will revert or a regime that has changed. The evidence points to a structural break, for three reasons.

First, the cost of capital that underwrote the model is gone for good. The 2010s offered a once-in-a-generation combination of falling rates and expanding multiples; a buyout firm could buy a company, add debt, and profit simply from the multiple rising as rates fell. That tailwind has reversed. Even as rates moderate, they are unlikely to return to the zero bound, which means leverage is permanently more expensive and exit multiples face a higher discount rate.

Second, the industry's scale has made it its own obstacle. A decade ago, private equity held roughly 16,000 companies; today it holds more than twice that many. The assets under management of the largest firms have grown so large that even successful exits move a smaller percentage of the backlog. Megadeals cannot solve a problem measured in tens of thousands of mid-market companies.

Third, the distribution drought has broken the compact with limited partners. Four years of distributions below 15% of NAV has forced pension funds and endowments to re-underwrite the asset class. Allocators are not merely delaying commitments; they are consolidating manager rosters and shifting toward secondaries to gain liquidity. That behavioral change outlasts any single rate cut.

The counter-thesis is that this is a solvable cyclical backlog, and it has serious support. Exits are recovering unevenly but recovering: the Medline IPO proved that public markets will absorb quality sponsor-backed listings; Europe's sponsor-to-sponsor market is running at record share; and a 2026 IPO pipeline that could put private equity at the center of new listings points to a functioning exit environment returning. Interest rates are coming down. Corporate M&A remains robust. If the backlog clears over two to three years, the industry returns to its historical rhythm, and today's fundraising pain is simply the trough before the next vintage cycle. Hugh MacArthur, who leads Bain's global private equity practice, has framed the moment not as a crisis but as a stuck point - a distinction that implies the machinery still works once confidence returns.

That view has merit but understates the damage that time has already done. Every year an asset sits unsold is a year in which IRR stagnates and LP patience thins. The falsifying signal for the structural-break view is specific: if private-equity-backed listings exceed one-third of all 2026 IPOs and distributions as a percentage of NAV rise back above 15% in 2026, then the exit machine has truly restarted and the limbo was cyclical. If neither prints, the industry is living with a smaller, more concentrated, slower-turning business model for the rest of the decade.

What Comes Next

Short term (the next two to three quarters): expect choppy activity rather than a boom. More assets will come to market, but the percentage of marketed deals that close - already trending lower in the second half of 2024 - must turn positive before the backlog meaningfully shrinks. NAV-backed financing and continuation vehicles will keep rising as stopgaps; they now account for less than 10% of exit value and relieve pressure but do not solve it.

Medium term (two to three years): the industry works through the strongest of the unsold companies, while weaker assets face write-downs or sales at prices below their marked values. Fundraising consolidates around managers with proven distribution records. The six largest listed managers - Apollo, Ares, Blackstone, Carlyle, KKR and TPG - are positioned to gain share as capital concentrates, even as the broader field shrinks.

Long term: private equity survives but in a structurally altered form - smaller relative to the boom, more selective, with longer hold periods accepted as the norm rather than the exception. Returns will depend less on financial engineering and more on the operational improvement that the industry has always claimed to deliver.

The winners in this environment are strategic corporate buyers with balance sheets and specific needs, top-tier sponsors with distribution track records, and the secondary market that monetizes LP impatience. The exposed are the mid-tier and first-time managers whose value proposition was built on a cost of capital that no longer exists, and the pension funds that locked capital into funds with no clear path to liquidity.

"Private equity is stuck because those companies have failed to fulfill their value promise," said Andrew Milgram, managing partner and chief investment officer at Marblegate Asset Management.

The limbo will end one of two ways: either valuations reset to meet the market, or the market resets to meet valuations. History suggests the former - and that the private equity industry that emerges on the other side will look smaller, slower, and less certain of its own returns than the one that entered the 2020s.

Explore more exclusive insights at nextfin.ai.

Insights

Why is private equity in limbo now?

How many unsold companies remain today?

What caused exit machine to stop?

Why did deal value rise not exits?

How long are assets held today?

What defines PE distribution drought?

How do rates impact PE valuations?

Why do megadeals fail to clear backlog?

What role do IPOs play in exits?

Are sponsor sales a real solution?

What are NAV-backed loans risks?

Is this a cycle or structural break?

How will PE fundraising change soon?

Who wins in this new PE landscape?

What happens to mid-tier managers?

How does Medline IPO signal hope?

Why did fundraising fall 30 percent?

What defines the fee model mismatch?

Will valuations reset meet market?

How does dry powder affect deals?

Search, ask or analyze anything...